UBS Group’s Quanome Technologies, Inc. Common Stock QNME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$756 Buy
1,085
+617
+132% +$490 ﹤0.01% 9756
2025
Q4
$417 Buy
468
+464
+11,600% +$488 ﹤0.01% 9978
2025
Q3
$5 Sell
4
-18,427
-100% -$18.1K ﹤0.01% 10234
2025
Q2
$15.7K Buy
+18,431
New +$17.8K ﹤0.01% 8598
2025
Q1
Sell
-17,199
Closed -$43K 10846
2024
Q4
$43K Buy
17,199
+14,201
+474% +$38K ﹤0.01% 7393
2024
Q3
$10.9K Buy
2,998
+2,059
+219% +$6.36K ﹤0.01% 7707
2024
Q2
$3.77K Buy
+939
New +$3.77K ﹤0.01% 8174

Other funds holding QNME

UBS Group's QNME Position: Q1 2026 in Review

UBS Group increased its Quanome Technologies, Inc. Common Stock (QNME) stake by 132% in Q1 2026, buying an estimated $490 and bringing the position to 1,085 shares worth $756. The position accounts for ﹤0.01% of the portfolio, ranked #9756.

UBS Group first reported a position in QNME in Q2 2024 and has held it in 7 quarters since. The position peaked at $43K in Q4 2024. 7 funds tracked by Wall St. Rank hold QNME as of Q1 2026.

  • UBS Group held 1,085 shares of Quanome Technologies, Inc. Common Stock worth $756 as of Q1 2026.
  • UBS Group bought 617 Quanome Technologies, Inc. Common Stock shares in Q1 2026, an estimated $490.
  • Quanome Technologies, Inc. Common Stock made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9756 holding.
  • UBS Group first reported a position in Quanome Technologies, Inc. Common Stock in Q2 2024 and has held it in 7 quarters since.
  • UBS Group's Quanome Technologies, Inc. Common Stock position peaked at $43K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Quanome Technologies, Inc. Common Stock as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.